BACH2 and neoplasm: In support of this, BACH2 was recently shown to specifically restrain TCR-driven TReg activation and actively drive TReg quiescence [45], thereby indicating BACH2 functions to promote tumour immunosuppression by both upholding a durable TReg precursor pool and also maintaining TRegs functionally quiescent.